MONDAY, NOVEMBER 12, 2012 (3:30 pm PST/6:30 pm EST)
We are excited to present a Reach2HD update from the following amazing individuals:
Dr. Martha Nance is the Director of the HD COE. She is a co-author of “The Physician’s Guide to HD” and “The Juvenile HD Handbook”, and a past member of the Executive Committee of the Huntington Study Group.  She is a member of the Steering Committee of Predict-HD and Enroll-HD, and has been a participant in many HD clinical research trials over the last 20 years.
Sarah Janicki is an Assistant Professor in the Department of Neurology at Columbia University Medical Center. Dr. Janicki spent part of her fellowship training in the HDSA Center of Excellence at Columbia, and was happy to rejoin the staff there in early 2011 as a faculty member. Her research involves the effects of hormones and gender on neurodegenerative disorders.
Ronda Clouse, RN  joined the HD team at Columbia  in 2004.  She has 25 years of research experience working with cognitively impaired neurological and psychiatric patients.  She provides general support for several HD research protocols and the HD Center clinic, and Coordinates the Reach2HD study at Columbia, New York.
Carlos Singer MD is the Chief of the Division of Movement Disorders at the University of Miami He has chaired one of the working groups for the Parkinson Study Group and has been a member of the Education Committee of the Huntington Study Group. He directs the Huntington Clinic at the University of Miami and has participated in observational and clinical trials of Huntington disease.
Amy Duffy has been a study coordinator specializing in Neurological Movement Disorders at the Mayo Clinic in Arizona for the last 4 years.